Dickinson

Med Device Company Pays $175m Penalty for Misleading Investors Over Compliance Issues

Medical device giant Becton, Dickinson to pay $175M SEC fine for concealing safety risks of its Alaris infusion pump, which generated 10% of company revenues. FDA clearance issues and software problems threatened future sales.

Digital Sponsors

Become a Sponsor

What's New

EU Sets Plan to Become Global Leader in AI Technology

High Intensity Radiated Fields (HIRF), Part 4

FCC Issues Limited Delay in TCPA Implementation

Efforts Underway to Save Marconi Radio Towers in Canada

FDA Struggles to Meet Product Review Deadlines

- From Our Sponsors -